NEVVI Medicare utilization intelligence

← back

THOMPSON, DANAM.D. NPI 1306862669 Clinician

Medical Oncology · NASHVILLE, TN

Specialty Medical Oncology — from billed Medicare claims
Trained UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 38 years since medical school (class of 1988, self-reported to CMS)
Location NASHVILLE, TN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 72 codes billed · 101,703 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TENNESSEE ONCOLOGY PLLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2012-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J0640 Injection, leucovorin calcium, per 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82784 Gammaglobulin (immune system protein) measurement
J9190 Injection, fluorouracil, 500 mg
83521 Measurement of immunoglobulin light chains
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
83615 Lactate dehydrogenase (enzyme) level
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
82607 Cyanocobalamin (vitamin b-12) level
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96415 Administration of chemotherapy into vein, each additional hour
82746 Folic acid level, serum
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
82378 Carcinoembryonic antigen (cea) protein level
83735 Magnesium level
82232 Beta-2 microglobulin (protein) level
96417 Administration of additional new drug or substance into vein, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
84443 Blood test, thyroid stimulating hormone (tsh)
84550 Uric acid level, blood
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84153 Psa (prostate specific antigen) measurement, total
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
84439 Thyroxine (thyroid chemical), free
82533 Cortisol (hormone) measurement, total
81003 Automated urinalysis test
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J7030 Infusion, normal saline solution , 1000 cc
80048 Blood test, basic group of blood chemicals (calcium, total)
96411 Administration of additional new drug or substance into vein using push technique
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96361 Infusion into a vein for hydration, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
82668 Erythropoietin (protein) level
83010 Haptoglobin (serum protein) level
96360 Infusion into a vein for hydration, 31-60 minutes
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
82306 Vitamin d-3 level
96374 Injection of drug or substance into vein
84100 Phosphate level
38222 Biopsy and aspiration of bone marrow sample for diagnosis
88313 Special stained specimen slides to examine tissue including interpretation and report
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
90653 Influenza vaccine, inactivated
G0008 Administration of influenza virus vaccine
J2060 Injection, lorazepam, 2 mg
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
85045 Red blood count, automated test
85652 Red blood cell sedimentation rate, to detect inflammation, automated

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.